对于舌癌复发性颈淋巴结转移患者，在使用纳武单抗治疗进展后成功再次使用西妥昔单抗治疗。

Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue.

Asada Yasuyuki, Teramura Chitoshi, Wada Takuma, Machida Yoshisato, Koshinuma Shinya, Yamamoto Gaku

Department of Oral and Maxillofacial Surgery Shiga University of Medical Science Shiga Japan.

Department of Oral and Maxillofacial Surgery Otsu City Hospital Shiga Japan.

Clin Case Rep. 2021 Jul 16;9(7):e04464. doi: 10.1002/ccr3.4464. eCollection 2021 Jul.

We can infer that the immunostimulatory effect of nivolumab and reactivation of cetuximab enhance the antitumor effect of the therapy.

Successful rechallenge with cetuximab after progression with nivolumab for recurrent cervical lymph node metastasis from carcinoma of the tongue.